Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

What can those experiencing cancer and its overwhelming unpredictability teach us about dealing with COVID-19?
Leadership Panel Addresses Top Issues in Oncology Care BY CHRISTIAN G. DOWNS, JD, MHA In April, at the virtual 2020 Community Oncology Alliance Annual Conference, leaders across the cancer care community gathered online for a panel discussion of current events and policy priorities in oncology care. COVID-19 and its fallout on community cancer centers dominated the discussion, which was …
Though tumor boards continue to be the standard for multidisciplinary conferences in most cancer programs, the evolving nature of medicine and the merging of individual provider organizations into large healthcare institutions have made this process impractical. Increasingly, traditional tumor boards are giving way to prospective multidisciplinary conferences that allow ongoing evaluation of a patient …
Medicare Administrative Contractors (MACs) act on behalf of the Centers for Medicare & Medicaid Services (CMS) as a direct point of contact for claims submission and payment, policy establishment, and special pricing of services.
60 accc-cancer.org | July–August 2020 | OI action CHI Saint Joseph Lexington Cancer Center Lexington, Kentucky Delegate Rep: Greg Bodager, MSN Website: chisaintjosephhealth.org/lexington-cancer-care Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne, Ind. Delegate Rep: Carrie Asher Website: fwmoh.com Scotland Memorial Hospital Scotland Cancer Treatment Center Laurinburg, …
14 accc-cancer.org | July–August 2020 | OI L ocated in central Montana, Benefis Sletten Cancer Institute provides multidisciplinary cancer care to a vast 13-county region bordering the Rocky Mountains. This catchment area is larger than the states of Connecticut, Delaware, New Hampshire, New Jersey, and Vermont combined and is home to a rural population of about 164,000 people. Benefis …
Our results indicated that food insecure patients tended to complete fewer months of treatment than their food secure counterparts. Food insecure patients who refused assistance had the lowest number of months of completed treatment; most food insecure patients who received assistance completed more of their treatment.
In 2018 the Oncology Service Line recognized the potential to improve the patient experience with the development and implementation of a mobile radiation oncology application (app). This app supports the healthcare organization’s goal to deliver a patient experience that is simpler, builds loyalty, and reduces patient anxiety.
Co-designing a model with patients, survivors, and the community.
ONCOLOGY ISSUES This publication is a benefit of membership Association of Community Cancer Centers July | August 2020 Developing and implementing a radiation oncology app to improve the patient experience | 46 Improving cancer care by addressing food insecurity and identifying community resources | 36 Co-designing a cancer program with patients, survivors, and the community …
COVID-19 has brought an unexpected, unwelcome, and unwanted disruption to oncology care, as it has to every other facet of life. ACCC has met this unprecedented pandemic, however, with its characteristic “how to” approach.
10 accc-cancer.org | July–August 2020 | OI Approved Drugs • On May 22, the U.S. Food and Drug Administration (FDA) approved Alunbrig® (brigatinib) (Takeda Pharmaceutical Company Limited, takeda.com/en-us/) for adult patients with anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer as detected by an FDA-approved test. • On April 8, the FDA approved …
How does one go about eating an elephant? One bite at a time. - Desmond Tutu, Nobel Laureate The SARS-CoV-2 epidemic has illustrated to us the life and death consequences of unequal access to healthcare and the racial disparities in treatment outcomes in the U.S. In the oncology community, efforts to identify, address, and eliminate disparities and inequities in cancer care are ongoing. With …
1 ACCC Research Review: July 2020 A Message from the President's Task Force By Randall A. Oyer, MD Clinical trials need to be more inclusive of Black and African American, Latinx, and older adult patients, as well as other historically under-represented groups. Equitable representation in and access to cancer clinical trials is essential to truly closing the gap in cancer …
Learn about Ochsner Cancer Center’s testing strategy for COVID-19 and how you can adapt their guidance when establishing your own testing protocols.
By Christopher Kerns and Amanda Berra of the Advisory Board Note: This blog post is a segment of an article that was originally published on June 15, 2020 by the Advisory Board. With telehealth reimbursement finally seeing reimbursement parity with in-person visits during the public health emergency, providers of all stripes have begun investing heavily in a variety of platforms. Here, John …
Rockville, MD— The Association of Community Cancer Centers (ACCC) Immuno-Oncology Institute has released an assessment of the current state of Immuno-Oncology, highlighting for cancer care professionals current research, utilization trends, and coming advances for immunotherapies (IO). The cancer community marks June as Cancer Immunotherapy Month. The report, titled, “Immuno-Oncology in 2020: What …
June 26, 2020
Join Raju K. Vaddepally, MD, Yuma Regional Medical Center Cancer Center, to discuss strategies for sustaining a robust clinical trials program in uncertain times and how to increase the relevance of research to vulnerable and underserved patients. (June 26, 2020)
In recognition of Cancer Immunotherapy Month, ACCCBuzz talked to Sigrun Hallmeyer, MD, the chair of the ACCC Immuno-Oncology Institute’s Executive Committee.
Rockville, MD— The Association of Community Cancer Centers (ACCC) today released the following statement from ACCC president, Dr. Randall A. Oyer, in response to recent comments by Norman E. Sharpless, MD, National Cancer Institute Director, on COVID-19 impact on cancer deaths for years to come. Dr. Sharpless expressed concerns about delays in screening and altering cancer treatment regimens due to …